Luminer, a labeling solutions provider specializing in extended content labels (ECLs) for pharmaceutical ethical and OTC packaging, has incorporated a new ECL production line at its primary manufacturing facility in Lakewood, NJ. Highlighted by a custom engineered modular printing, converting, onserting servo platform, the new infrastructure expands Luminer’s capacity and adds faster throughput speeds and heightened booklet placement precision.

The seven-figure investment doubles Luminer’s ECL manufacturing capacity and allows the company to accommodate its growing extended content label business. The new line’s production speeds foster both efficiency and cost-effectiveness, ROIs that Luminer will be able to pass on to customers.

The equipment also helps Luminer expand its overall ECL capabilities portfolio with modernized onserting and movable print and die stations as well as expand production flexibility, including customized arrangements often utilized in clinical trials and other pharmaceutical product settings.

Some of the factors surrounding the increasing need for extended content labels include: warnings and directives that comply with regulatory guidelines, serialization and traceability requirements, different languages, specific, detailed instructions.

Register as Visitor to CPhI China 2020!

-----------------------------------------------------------------------
Editor's Note:

En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,

for any copyright disputes involved in the articles,

please email: Julia.Zhang@imsinoexpo.com to motify or remove the content.